ProShares Trust II — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ProShares Trust II filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.71B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($39.37M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($2.48B) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $95.78M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($1.68B) | Nov 18, 2024 |
| FY2022 | Dec 31, 2020 | ($1.28B) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($423.74M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | ($1.53B) | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | ($458.46M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | ($1.20B) | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($246.30M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $208.80M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($1.54B) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.16B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($3.21B) | Nov 18, 2024 |
| FY2022 | Dec 31, 2020 | ($1.31B) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($783.65M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $201.69M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $133.78M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.11B | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.06B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.15B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.37B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $3.95B | Nov 18, 2024 |
| FY2022 | Dec 31, 2021 | $4.26B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $4.53B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $2.42B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.07B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $3.07B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.39B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $338.87M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $126.79M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $87.39M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $59.10M | Nov 18, 2024 |
| FY2022 | Dec 31, 2021 | $84.59M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $55.51M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $62.40M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $127.04M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $118.47M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $117.24M | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.72B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.03B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.28B | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $3.89B | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $4.17B | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $4.47B | Nov 18, 2024 |
| FY2022 | Dec 31, 2019 | $2.36B | Feb 28, 2023 |
| FY2021 | Dec 31, 2018 | $1.94B | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $2.95B | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | $3.28B | Feb 28, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $55.71M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $39.48M | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $48.05M | Mar 1, 2018 |
| FY2017 | Dec 31, 2014 | $35.90M | Mar 1, 2018 |
| FY2016 | Dec 31, 2013 | $23.39M | Mar 1, 2017 |
| FY2015 | Dec 31, 2012 | $19.96M | Feb 29, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 123.83M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 86.35M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 82.62M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 87.12M | Nov 18, 2024 |
| FY2022 | Dec 31, 2021 | 179.85M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 88.46M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 110.92M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 75.84M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 74.00M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 90.24M | Mar 1, 2018 |